ロード中...
Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
OBJECTIVE: The objective of this clinical trial is to study the effectiveness of administering recombinant activated factor VII (rFVIIa) in reducing the amount of bleeding and the need for homologous blood and products transfusion in cardiac surgical coronary revascularization procedures done under...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3757804/ https://ncbi.nlm.nih.gov/pubmed/24015134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1658-354X.115364 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|